Evidence map›Paper›PMID 39000644›Full record

ArticlePolymers2024

Electrospun Composites of Chitosan with Cerium Oxide Nanoparticles for Wound Healing Applications: Characterization and Biocompatibility Evaluation In Vitro and In Vivo.

Valentina A Petrova, Daria N Poshina, Alexey S Golovkin, Alexander I Mishanin, Sergei G Zhuravskii, Galina Y Yukina, Maria Y Naumenko, Elena G Sukhorukova, Nikita A Savin, Alexander S Erofeev and 5 more

Abstract read
In one paragraph

Article in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Valentina A PetrovaInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.
Daria N PoshinaInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.ORCID 0000-0001-5342-0605
Alexey S GolovkinAlmazov National Medical Research Centre, Akkuratova 2, 197341 St. Petersburg, Russia.ORCID 0000-0002-7577-628X
Alexander I MishaninAlmazov National Medical Research Centre, Akkuratova 2, 197341 St. Petersburg, Russia.ORCID 0000-0003-3948-1799
Sergei G ZhuravskiiHearing and Speech Laboratory, Pavlov First Saint Petersburg State Medical University, L'va Tolstogo 6-8, 197022 St. Petersburg, Russia.
Galina Y YukinaLaboratory of Pathomorphology, Pavlov First Saint Petersburg State Medical University, L'va Tolstogo 6-8, 197022 St. Petersburg, Russia.
Maria Y NaumenkoHearing and Speech Laboratory, Pavlov First Saint Petersburg State Medical University, L'va Tolstogo 6-8, 197022 St. Petersburg, Russia.
Elena G SukhorukovaLaboratory of Pathomorphology, Pavlov First Saint Petersburg State Medical University, L'va Tolstogo 6-8, 197022 St. Petersburg, Russia.
Nikita A SavinLaboratory of Biophysics, National University of Science and Technology "MISIS", Leninsky 4, 119049 Moscow, Russia.ORCID 0000-0001-9199-7229
Alexander S ErofeevLaboratory of Biophysics, National University of Science and Technology "MISIS", Leninsky 4, 119049 Moscow, Russia.
Iosif V GofmanInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-1939-2660
Elena M Ivan'kovaInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-4823-0695
Natallia V DubashynskayaInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-4399-9374
Alexander V YakimanskyInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.
Yury A SkorikInstitute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-9731-6399

Funding

Russian Science Foundation 22-13-00068
6 · The paper itself

Abstract

Cerium oxide nanoparticles (CeONPs), as part of tissue regeneration matrices, can protect cells from reactive oxygen species and oxidative stress. In addition, they can influence the properties of the scaffold, including its electrospinnability and mechanical strength. In this work, we prepared electrospun fiber mats from a chitosan and polyethylene oxide blend (CS-PEO) with the addition of ceria nanoparticles (CS-PEO-CeONP). The addition of CeONPs resulted in a smaller fiber diameter and higher swelling compared to CS-PEO fiber mats. CeONP-modified fiber mats also had a higher Young's modulus due to the reinforcing effect of the nanoparticles. Both mats had comparable adhesion and cytocompatibility to mesenchymal stem cells, which had a more rounded morphology on CS-PEO-CeONP compared to elongated cells on the CS-PEO mats. Biocompatibility in an in vivo rat model showed no acute toxicity, no septic or allergic inflammation, and no rough scar tissue formation. The degradation of both mats passed the stage of matrix swelling. CS-PEO-CeONP showed significantly slower biodegradation, with most of the matrix remaining in the tissue after 90 days. The reactive inflammation was aseptic in nature with the involvement of multinucleated foreign-body type giant cells and was significantly reduced by day 90. CeONPs induced the formation of the implant's connective tissue capsule. Thus, the introduction of CeONPs influenced the physicochemical properties and biological activity of CS-PEO nanofiber mats.

Indexed as

cerium oxidechitosanelectrospinningtissue engineeringwound dressing

Identifiers

PMID39000644
PMCPMC11243935

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.